Omega Healthcare Investors Stock Current Valuation
| WX4 Stock | EUR 34.17 0.21 0.61% |
Valuation analysis of Omega Healthcare Inv helps investors to measure Omega Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Omega Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Omega Healthcare Inv is based on 3 months time horizon. Increasing Omega Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Omega stock is determined by what a typical buyer is willing to pay for full or partial control of Omega Healthcare Investors. Since Omega Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Omega Stock. However, Omega Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 34.17 | Real 29.79 | Hype 34.38 | Naive 34.17 |
The real value of Omega Stock, also known as its intrinsic value, is the underlying worth of Omega Healthcare Inv Company, which is reflected in its stock price. It is based on Omega Healthcare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Omega Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Omega Healthcare Investors helps investors to forecast how Omega stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Omega Healthcare more accurately as focusing exclusively on Omega Healthcare's fundamentals will not take into account other important factors: Omega Healthcare Investors Company Current Valuation Analysis
Omega Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Omega Healthcare Current Valuation | 11.43 B |
Most of Omega Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Omega Healthcare Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Omega Healthcare Investors has a Current Valuation of 11.43 B. This is 24.68% lower than that of the Real Estate sector and 7.22% lower than that of the REIT - Healthcare Facilities industry. The current valuation for all Germany stocks is 31.26% higher than that of the company.
Omega Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Omega Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Omega Healthcare could also be used in its relative valuation, which is a method of valuing Omega Healthcare by comparing valuation metrics of similar companies.Omega Healthcare is currently under evaluation in current valuation category among its peers.
Omega Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0258 | |||
| Profit Margin | 0.49 % | |||
| Operating Margin | 0.45 % | |||
| Current Valuation | 11.43 B | |||
| Shares Outstanding | 234.27 M | |||
| Shares Owned By Insiders | 0.39 % | |||
| Shares Owned By Institutions | 67.90 % | |||
| Price To Earning | 24.84 X | |||
| Price To Book | 1.85 X | |||
| Price To Sales | 6.72 X | |||
| Revenue | 878.24 M | |||
| Gross Profit | 794.08 M | |||
| EBITDA | 1 B | |||
| Net Income | 426.93 M | |||
| Cash And Equivalents | 40.03 M | |||
| Cash Per Share | 0.19 X | |||
| Total Debt | 5.27 B | |||
| Debt To Equity | 116.70 % | |||
| Current Ratio | 2.17 X | |||
| Book Value Per Share | 15.41 X | |||
| Cash Flow From Operations | 625.73 M | |||
| Earnings Per Share | 1.70 X | |||
| Target Price | 38.0 | |||
| Number Of Employees | 52 | |||
| Beta | 0.96 | |||
| Market Capitalization | 6.13 B | |||
| Total Asset | 9.41 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.1 % | |||
| Five Year Return | 6.56 % | |||
| Net Asset | 9.41 B | |||
| Last Dividend Paid | 2.68 |
About Omega Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Omega Healthcare Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omega Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omega Healthcare Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Omega Stock
When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.